NOV Mono expands operation in Germany
Pumps specialist aims to grow Mono Universal Parts across Europe
Svetla Laskova will be located in Berlin and Werner Potrafke will be working near Bochum. Both have language skills and sales and business development experience in the industrial and engineering sectors.
According to Martyn Turner, Universal Parts product manager at Mono, there is a significant market for progressing cavity (PC) pumps in Germany and until recently buyers have had to purchase replacement parts from the OEM.
‘Mono manufactures a range of Universal Parts designed for use in other branded PC pumps and these two new appointments will help us to promote the benefits of the brand and our PC pump technology to the waste water market in Germany,’ he said.
The full range of Mono Universal Parts includes rotors, stators, coupling rods, shafts, pins/bushes, seals and drive train assemblies for use in Seepex, Netzsch, PCM, Allweiler, Robbins & Myers, Bornemann and Orbit pumps.
Based in Manchester, UK, NOV Mono Group has more than 700 authorised distributors worldwide and employs around 750 people.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region